Molinaro C, Martoriati A, Pelinski L, Cailliau K
Discontinuation rates due to AEs were 12.2% and 18.2% with Retatrutide 9 mg and 12 mg, respectively, compared to 4% with placebo
Potential Side Effects and Safety Considerations Whilst combination therapy with GLP-1 receptor agonists and SGLT2 inhibitors is generally well-tolerated, patients and healthcare professionals must be aware of potential adverse effects associated with each drug class
The PK measurements normalized when hydrocortisone was given before a meal and exenatide 1.5 h after that meal
The Microdose GLP-1 Protocol ($129/month) introduces tirzepatide at lower physiologic doses, allowing gradual adaptation and reducing adjustment-phase symptoms while maintaining therapeutic benefit
These green light cuts offer the highest protein-to-calorie ratio and are naturally low in fat, making them easier on your digestive system